Four Senate Finance Committee members, two from each party, are asking the trade community to submit suggestions "in detail" on how they want the customs modernization trade facilitation planks improved.
CBP issued the following releases on commercial trade and related matters:
CBP released a new fact sheet June 13 detailing how customs brokers can update and submit information using Modernized ACE. The fact sheet, "Broker Permit Reporting Capabilities in Modernized ACE," goes over the required reporting needed in the ACE portal, the optional reporting and viewing that can be done in the ACE portal, and additional resources for brokers.
CBP issued the following releases on commercial trade and related matters:
CBP issued the following releases on commercial trade and related matters:
CBP posted the following documents ahead of the June 14 Commercial Customs Operations Advisory Committee (COAC) meeting:
CBP issued the following releases on commercial trade and related matters:
CBP issued the following releases on commercial trade and related matters:
The suspension of Section 232 duties on steel articles from Ukraine has been extended for another year and now includes steel from the EU melted and poured in Ukraine, CBP said as part of its guidance on June 5. The suspension is now set to expire on June 1, 2024. Importers must report the certificate of origin for Ukrainian steel or steel articles into the CBP’s Document Imaging System (DIS), the announcement said. If steel or steel deratives are not accompanied by certificates of origin from Ukraine, those items will be subject to the "25 percent ad valorem duty," the guidance said. Importers also must submit the steel mill certificate required by 19 CFR 141.89, the guidance said. The suspension of Section 232 duties is available in the Automated Commercial Environment (ACE), the guidance said. The extension of the suspension was announced on May 31. The suspension was first announced on May 27, 2022, (see 2205310061).
.FDA's estimate of the work required to file an entry "does not begin to account for the work required to file an FDA import entry," the National Customs Brokers & Forwarders Association of America said in comments on an FDA notice that sought input on the burden of its import entry process.